MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2016-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbalip.2016.04.020PMID 27155217PMCID PMC5097035
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 3’UTR Shortening Potentiates MicroRNA-Based Repression of Pro-differentiation Genes in Proliferating Human Cells

  2016cited by this paper
• MicroRNA as Biomarkers and Diagnostics

  2016cited by this paper
• Distribution of miRNA expression across human tissues

  2016cited by this paper
• The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs

  2015cited by this paper
• microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain

  2015cited by this paper
• Spinal muscular atrophy—recent therapeutic advances for an old challenge

  2015cited by this paper
• Emerging role of microRNAs in lipid metabolism

  2015cited by this paper
• Small molecule chemical probes of microRNA function.

  2015cited by this paper
• Direct intracerebral delivery of a miR-33 antisense oligonucleotide into mouse brain increases brain ABCA1 expression. [Corrected].

  2015cited by this paper
• The Role of Cholesterol Metabolism in Alzheimer’s Disease

  2014cited by this paper
• Apolipoprotein E in Synaptic Plasticity and Alzheimer’s Disease: Potential Cellular and Molecular Mechanisms

  2014cited by this paper
• Regulation of microRNA biogenesis

  2014cited by this paper
• microRNAs and HDL life cycle.

  2014cited by this paper
• Pharmacology of a Central Nervous System Delivered 2′-O-Methoxyethyl–Modified Survival of Motor Neuron Splicing Oligonucleotide in Mice and Nonhuman Primates

  2014cited by this paper
• Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice

  2014cited by this paper
• Growth of the developing cerebral cortex is controlled by microRNA-7 through the p53 pathway.

  2014cited by this paper
• microRNA regulation of lipoprotein metabolism

  2014cited by this paper
• Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues

  2014cited by this paper
• What are lipoproteins doing in the brain?

  2014influential reference
• Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

  2013cited by this paper
• MicroRNA-144 Regulates Hepatic ATP Binding Cassette Transporter A1 and Plasma High-Density Lipoprotein After Activation of the Nuclear Receptor Farnesoid X Receptor

  2013cited by this paper
• Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRα expression and cholesterol homeostasis

  2013cited by this paper
• MicroRNA-1 and microRNA-206 suppress LXRα-induced lipogenesis in hepatocytes.

  2013cited by this paper
• MicroRNAs and Cardiovascular Disease

  2013cited by this paper
• Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding

  2013cited by this paper
• Regulation of cholesterol homeostasis.

  2013cited by this paper
• MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice

  2013cited by this paper
• Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

  2013cited by this paper
• MicroRNAs and metabolism crosstalk in energy homeostasis.

  2013cited by this paper
• Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

  2013cited by this paper
• Comprehensive Expression Analyses of Neural Cell-Type-Specific miRNAs Identify New Determinants of the Specification and Maintenance of Neuronal Phenotypes

  2013cited by this paper
• MicroRNA-22 (miR-22) Overexpression Is Neuroprotective via General Anti-Apoptotic Effects and May also Target Specific Huntington’s Disease-Related Mechanisms

  2013cited by this paper
• Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

  2013cited by this paper
• Regulation of ABCA1 Protein Expression and Function in Hepatic and Pancreatic Islet Cells by miR-145

  2013cited by this paper
• MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression.

  2012cited by this paper
• ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

  2012cited by this paper
• Smith–Lemli–Opitz syndrome: Phenotype, natural history, and epidemiology

  2012cited by this paper
• Trafficking and proteolytic processing of APP.

  2012cited by this paper
• An alternative mode of microRNA target recognition

  2012cited by this paper
• Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent Aβ Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice

  2012cited by this paper
• SREBPs: metabolic integrators in physiology and metabolism.

  2012cited by this paper
• Apolipoprotein e sets the stage: response to injury triggers neuropathology.

  2012cited by this paper
• Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice.

  2012influential reference
• Alzheimer’s Disease: The Challenge of the Second Century

  2011cited by this paper
• Conserved Regulation of p53 Network Dosage by MicroRNA–125b Occurs through Evolving miRNA–Target Gene Pairs

  2011cited by this paper
• MicroRNA-758 Regulates Cholesterol Efflux Through Posttranscriptional Repression of ATP-Binding Cassette Transporter A1

  2011cited by this paper
• Cholesterol: A Novel Regulatory Role in Myelin Formation

  2011cited by this paper
• Pervasive roles of microRNAs in cardiovascular biology

  2011cited by this paper
• Linking lipids to Alzheimer's disease: cholesterol and beyond

  2011cited by this paper
• Linking lipids to Alzheimer's disease: cholesterol and beyond

  2011cited by this paper
• Regulation of cholesterol homeostasis

  2011cited by this paper
• MicroRNA-137/181c Regulates Serine Palmitoyltransferase and In Turn Amyloid β, Novel Targets in Sporadic Alzheimer's Disease

  2011cited by this paper
• Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

  2011cited by this paper
• Cholesterol metabolism in Huntington disease

  2011cited by this paper
• Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β Amyloidosis

  2011cited by this paper
• Cholesterol metabolism in neurons and astrocytes.

  2011cited by this paper
• MicroRNA hsa-miR-613 targets the human LXRα gene and mediates a feedback loop of LXRα autoregulation.

  2011cited by this paper
• Lipid metabolism and glial lipoproteins in the central nervous system.

  2011cited by this paper
• Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

  2011cited by this paper
• MicroRNAs in lipid metabolism

  2011cited by this paper
• MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis

  2010cited by this paper
• MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo

  2010cited by this paper
• miR-33 links SREBP-2 induction to repression of sterol transporters

  2010cited by this paper
• Liver X receptor in cholesterol metabolism.

  2010influential reference
• Myelin, DIGs, and membrane rafts in the central nervous system.

  2010cited by this paper
• The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration.

  2010cited by this paper
• The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma.

  2010cited by this paper
• Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation*

  2010cited by this paper
• ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice*

  2010cited by this paper
• Deregulation of sphingolipid metabolism in Alzheimer's disease.

  2010cited by this paper
• Liposome-siRNA-Peptide Complexes Cross the Blood-Brain Barrier and Significantly Decrease PrPC on Neuronal Cells and PrPRES in Infected Cell Cultures

  2010cited by this paper
• Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses.

  2010influential reference
• Lipoprotein subfractions and cardiovascular disease risk

  2010cited by this paper
• MiR-33 Contributes to the Regulation of Cholesterol Homeostasis

  2010cited by this paper
• Evolutionary conservation and adaptation in the mechanism that regulates SREBP action: what a long, strange tRIP it's been.

  2009cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

  2009cited by this paper
• MicroRNA regulation of Alzheimer's Amyloid precursor protein expression.

  2009cited by this paper
• A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.

  2009cited by this paper
• Ablation of cholesterol biosynthesis in neural stem cells increases their VEGF expression and angiogenesis but causes neuron apoptosis

  2009cited by this paper
• In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brain.

  2009cited by this paper
• Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1-deficient mammalian cells.

  2009cited by this paper
• The role of apolipoprotein E in Alzheimer's disease.

  2009cited by this paper
• Most mammalian mRNAs are conserved targets of microRNAs.

  2008cited by this paper
• HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis.

  2008influential reference
• The blood-brain barrier in health and chronic neurodegenerative disorders.

  2008cited by this paper
• Principles of bioactive lipid signalling: lessons from sphingolipids

  2008cited by this paper
• Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

  2008cited by this paper
• ApoE promotes the proteolytic degradation of Abeta.

  2008cited by this paper
• Activity-dependent structural and functional plasticity of astrocyte-neuron interactions.

  2008cited by this paper
• Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease.

  2008cited by this paper
• Most Caenorhabditis elegans microRNAs Are Individually Not Essential for Development or Viability

  2007cited by this paper
• microRNA functions.

  2007cited by this paper
• Transvascular delivery of small interfering RNA to the central nervous system

  2007cited by this paper
• A mammalian microRNA expression atlas based on small RNA library sequencing.

  2007cited by this paper
• Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-β Peptide Generation*

  2007cited by this paper
• Mechanism of ATP-binding Cassette Transporter A1-mediated Cellular Lipid Efflux to Apolipoprotein A-I and Formation of High Density Lipoprotein Particles*

  2007cited by this paper
• Survival of adult neurons lacking cholesterol synthesis in vivo

  2007cited by this paper
• Activity‐dependent regulation of energy metabolism by astrocytes: An update

  2007cited by this paper
• The role of site accessibility in microRNA target recognition

  2007cited by this paper

• CRISPR editing of miR-33 restores ApoE lipidation and amyloid-β metabolism in ApoE4 sporadic Alzheimer's disease.

  2025cites this paper
• Cholesterol-modifying strategies for Alzheimer disease: promise or fallacy?

  2025cites this paper
• Therapeutic potential of mesenchymal stem cells on cholesterol homeostasis‐associated genes in AD‐like rats

  2025cites this paper
• Histological, microecological and transcriptomic physiological responses underlying hypoxia and reoxygenation adaptation in yellowtail kingfish (Seriola lalandi)

  2023cites this paper
• Amyloid Beta Alters the Expression of microRNAs Regulating HMGCR and ABCA1 Genes in Astrocytes of C57BL/6J Mice

  2023cites this paper
• Understanding the multifaceted role of miRNAs in Alzheimer’s disease pathology

  2023cites this paper
• Sporadic Alzheimer’s Disease- and Neurotoxicity-Related microRNAs Affecting Key Events of Tau-Driven Adverse Outcome Pathway Toward Memory Loss

  2022cites this paper
• Biomarkers in the diagnosis of neurodegenerative diseases

  2022cites this paper
• Neurodegenerative Diseases and Cholesterol: Seeing the Field Through the Players

  2021cites this paper
• miR-194-5p inhibits LPS-induced astrocytes activation by directly targeting neurexophilin 1

  2020cites this paper
• Novel therapeutic strategies for Alzheimer’s disease targeting brain cholesterol homeostasis

  2020cites this paper
• Cholesterol homeostasis: researching a dialogue between the brain and peripheral tissues.

  2020cites this paper
• Inhibition of microRNA-155 Alleviates Cognitive Impairment in Alzheimer's Disease and Involvement of Neuroinflammation.

  2019cites this paper
• The impact of lipids, lipid oxidation, and inflammation on AMD, and the potential role of miRNAs on lipid metabolism in the RPE

  2019cites this paper
• The Age-dependent Elevation of miR-335-3p Leads to Reduced Cholesterol and Impaired Memory in Brain.

  2018cites this paper
• The Protective Effects of Clams on Hypercholesterolemia in Late-Stage Triple-Transgenic Alzheimer’s Diseased Mice Hearts

  2018cites this paper
• miR-126 as a Therapeutic Agent for Diabetes Mellitus.

  2017cites this paper
• Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.

  2017cites this paper
• Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases

  2017cites this paper
• RNA‐binding proteins implicated in neurodegenerative diseases

  2017cites this paper
• Cellular cholesterol homeostasis and Alzheimer’s disease

  2017cites this paper
• Preface to: "microRNAs in lipid/energy metabolism and cardiometabolic disease".

  2016cites this paper
• Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease

  2016cites this paper